Qulipta and Cough aggravated - a phase IV clinical study of FDA data

Summary:

Cough aggravated is reported as a side effect among people who take Qulipta (atogepant), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Ubrelvy, and have Migraine.

The phase IV clinical study analyzes which people have Cough aggravated when taking Qulipta. It is created by eHealthMe based on reports of 3,582 people who have side effects when taking Qulipta from the FDA, and is updated regularly.

What is Qulipta?

Qulipta has active ingredients of atogepant. eHealthMe is studying from 3,605 Qulipta users. Check the latest studies of Qulipta.

What is Cough aggravated?

Cough aggravated is found to be associated with 2,434 drugs and 902 conditions by eHealthMe. Check the latest studies of Cough aggravated.

On Jul, 26, 2026

3,582 people reported to have side effects when taking Qulipta.
Among them, 21 people (0.59%) have Cough aggravated.

Among these 21 people:

How long have people been on Qulipta when they have Cough aggravated? *

What is the gender of people who have Cough aggravated when taking Qulipta? *

female: 100 %
male: 0.0 %

What is the age of people who have Cough aggravated when taking Qulipta? *

What are other drugs people take besides Qulipta? *

Ubrelvy: 6 people, 28.57%
Omeprazole: 4 people, 19.05%
Vitamin D3: 4 people, 19.05%
Claritin: 3 people, 14.29%
Albuterol Sulfate: 3 people, 14.29%
Lyrica: 2 people, 9.52%
Ondansetron Hydrochloride: 2 people, 9.52%
Opsumit: 2 people, 9.52%
Orenitram: 2 people, 9.52%
Potassium Chloride: 2 people, 9.52%

What are other side effects people have besides Cough aggravated? *

Migraine (headache): 6 people, 28.57%
Nausea (feeling of having an urge to vomit): 6 people, 28.57%
Headache (pain in head): 5 people, 23.81%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 23.81%
Asthma: 4 people, 19.05%
Hoarseness Or Changing Voice: 3 people, 14.29%
Oropharyngeal Pain: 3 people, 14.29%
Fatigue (feeling of tiredness): 3 people, 14.29%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 14.29%
Fever: 3 people, 14.29%

What are the existing conditions these people have? *

Migraine (headache): 9 people, 42.86%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 9.52%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.76%
Headache (pain in head): 1 person, 4.76%
Drowsiness: 1 person, 4.76%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.76%
Bone Disorder: 1 person, 4.76%
Asthma: 1 person, 4.76%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Qulipta and have Cough aggravated?

- Check whether Cough aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qulipta:

Qulipta (3,605 reports)

Browse all side effects of Qulipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cough aggravated:

Cough aggravated (2,435 drugs)

Browse all the conditions that are associated with Cough aggravated:

Cough aggravated (902 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atogepant (the active ingredients of Qulipta) and Qulipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.